Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow
Not Specified
|
abnormal erythrocyte morphology |
J:134980
|
abnormal kidney corticomedullary boundary morphology |
J:134980
|
abnormal Kupffer cell morphology |
J:134980
|
abnormal liver morphology |
J:134980
|
abnormal spleen white pulp morphology |
J:134980
|
anemia |
J:137709
|
anisocytosis |
J:134980
|
decreased erythrocyte cell number |
J:134980
|
decreased hematocrit |
J:134980
|
decreased hemoglobin content |
J:134980
|
decreased urine osmolality |
J:134980
|
enlarged spleen |
J:134980
|
extramedullary hematopoiesis |
J:134980
|
focal hepatic necrosis |
J:134980
|
increased liver iron level |
J:134980
|
increased spleen red pulp amount |
J:134980
|
kidney vascular congestion |
J:134980
|
liver vascular congestion |
J:134980
|
poikilocytosis |
J:134980
|
polychromatophilia |
J:134980
|
reticulocytosis |
J:134980
|
spleen vascular congestion |
J:134980
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow Slc12a4Rbc10/Slc12a4+
involves: 129 * BALB/c * C57BL/6J
|
abnormal erythrocyte physiology |
J:227339
|
abnormal liver morphology |
J:227339
|
abnormal lung morphology |
J:227339
|
abnormal pulmonary circulation |
J:227339
|
abnormal renal tubule morphology |
J:227339
|
enlarged spleen |
J:227339
|
hepatic necrosis |
J:227339
|
increased mesangial cell number |
J:227339
|
liver inflammation |
J:227339
|
microcytic anemia |
J:227339
|
premature death |
J:227339
|
reticulocytosis |
J:227339
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow Slc12a4Rbc10/Slc12a4Rbc10
involves: 129 * BALB/c * C57BL/6J
|
premature death |
J:227339
|
preweaning lethality, incomplete penetrance |
J:227339
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm3(HBG1,HBB)Tow
Not Specified
|
anemia |
J:137709
|
normal
hematopoietic system phenotype |
J:134980
|
normal
liver/biliary system phenotype |
J:134980
|
normal
renal/urinary system phenotype |
J:134980
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm3(HBG1,HBB)Tow Slc12a4Rbc10/Slc12a4Rbc10
involves: 129 * BALB/c * C57BL/6J
|
microcytic anemia |
J:227339
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm2(HBG1,HBD,HBB*)Ryan
Not Specified
|
abnormal proerythroblast morphology |
J:148521
|
anemia |
J:148521
|
anisopoikilocytosis |
J:148521
|
decreased hemoglobin content |
J:148521
|
decreased mean corpuscular volume |
J:148521
|
extramedullary hematopoiesis |
J:148521
|
hemolytic anemia |
J:148521
|
increased circulating bilirubin level |
J:148521
|
intermingled spleen red and white pulp |
J:148521
|
low mean erythrocyte cell number |
J:148521
|
polychromatophilia |
J:148521
|
premature death |
J:148521
|
reticulocytosis |
J:148521
|
spherocytosis |
J:148521
|
spleen hyperplasia |
J:148521
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm3(HBG1,HBB)Tow
Not Specified
|
abnormal definitive hematopoiesis |
J:148521
|
decreased hemoglobin content |
J:148521
|
decreased mean corpuscular volume |
J:148521
|
high mean erythrocyte cell number |
J:148521
|
reticulocytosis |
J:148521
|
spleen hyperplasia |
J:148521
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm3(HBG1,HBB)Tow/Hbbtm3(HBG1,HBB)Tow
Not Specified
|
anemia |
J:137709
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm4(HBB*)Tow/Hbbtm4(HBB*)Tow
Not Specified
|
abnormal erythrocyte physiology |
J:137709
|
anemia |
J:137709
|
normal
cardiovascular system phenotype |
J:137709
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm5(HBG1,HBB*)Tow/Hbbtm5(HBG1,HBB*)Tow
Not Specified
|
abnormal erythrocyte physiology |
J:137709
|
anemia |
J:137709
|
normal
cardiovascular system phenotype |
J:137709
|
Hbatm1Paz/Hba+ Hbbtm1Tow/Hbbtm1Tow
involves: 129S2/SvPas * 129S7/SvEvBrd
|
abnormal erythroid progenitor cell morphology |
J:204029
|
decreased erythroid progenitor cell number |
J:204029
|
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbb+
involves: 129S2/SvPas * 129S7/SvEvBrd
|
normal
hematopoietic system phenotype |
J:204029
|
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbbtm1Tow
involves: 129S2/SvPas * 129S7/SvEvBrd
|
abnormal embryonic erythrocyte morphology |
J:204029
|
abnormal embryonic erythropoiesis |
J:204029
|
abnormal erythroid progenitor cell morphology |
J:204029
|
decreased embryo size |
J:204029
|
decreased erythroid progenitor cell number |
J:204029
|
embryonic lethality during organogenesis, complete penetrance |
J:204029
|
liver hypoplasia |
J:204029
|
microcytic anemia |
J:204029
|
microcytosis |
J:204029
|
pallor |
J:204029
|
small liver |
J:204029
|
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbbtm1Tow Tg(HBA-HBBs)41Paz/0
involves: 129 * Black Swiss * C57BL/6 * DBA/2 * FVB/N
|
abnormal penile erection |
J:135978
|
priapism |
J:135978
|
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbbtm1Tow Tg(HBA-HBBs)41Paz/?
involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N
|
abnormal erythrocyte morphology |
J:44161
|
abnormal hemoglobin |
J:44161
|
abnormal kidney vasculature morphology |
J:44161
|
abnormal liver vasculature morphology |
J:44161
|
abnormal lung vasculature morphology |
J:44161
|
anemia |
J:44161
|
anisopoikilocytosis |
J:44161
|
decreased erythrocyte osmotic fragility |
J:44161
|
decreased hematocrit |
J:44161
|
decreased mean corpuscular hemoglobin |
J:44161
|
decreased mean corpuscular hemoglobin concentration |
J:44161
|
decreased mean corpuscular volume |
J:44161
|
hypoxia |
J:44161
|
increased heart weight |
J:44161
|
increased kidney iron level |
J:44161
|
increased kidney weight |
J:44161
|
increased liver iron level |
J:44161
|
increased spleen weight |
J:44161
|
kidney atrophy |
J:44161
|
kidney cyst |
J:44161
|
neonatal lethality, incomplete penetrance |
J:44161
|
renal fibrosis |
J:44161
|
reticulocytosis |
J:44161
|
spleen vascular congestion |
J:44161
|
Hbbd3th/Hbb+ Tg(HBB-AR-HBA2,-HBB*)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0
involves: FVB/N * Swiss Webster
|
abnormal erythrocyte morphology |
J:94190
|
abnormal urine homeostasis |
J:94190
|
anemia |
J:94190
|
decreased urine osmolality |
J:94190
|
increased circulating alanine transaminase level |
J:94190
|
increased circulating aspartate transaminase level |
J:94190
|
reticulocytosis |
J:94190
|
Hbbd3th/Hbb+ Tg(LCR-HBA1,LCR-HBB*)1Tow/0
involves: C57BL/6 * DBA/2J * SJL
|
anemia |
J:127701
|
anisopoikilocytosis |
J:127701
|
decreased erythrocyte cell number |
J:127701
|
decreased hematocrit |
J:127701
|
decreased hemoglobin content |
J:127701
|
echinocytosis |
J:127701
|
enlarged spleen |
J:127701
|
reticulocytosis |
J:127701
|
Hbbd3th/Hbb+ Tg(LCR-HBA2,LCR-HBB*)1Cos/0
involves: C57BL/6J * CBA/J * DBA/2J
|
abnormal erythrocyte morphology |
J:94193
|
abnormal gas homeostasis |
J:94193
|
abnormal hemoglobin |
J:94193
|
anemia |
J:94193
|
decreased hematocrit |
J:94193
|
decreased mean corpuscular volume |
J:94193
|
enlarged spleen |
J:94193
|
increased mean corpuscular hemoglobin concentration |
J:94193
|
increased susceptibility to induced morbidity/mortality |
J:94193
|
maternal effect |
J:94193
|
postnatal lethality, incomplete penetrance |
J:94193
|
reticulocytosis |
J:94193
|
Hbbd3th/Hbbd3th Tg(HBB-AR-HBA2,-HBB*)58Rub/0
involves: Swiss Webster
|
abnormal erythrocyte morphology |
J:136653
|
abnormal mean corpuscular volume |
J:136653
|
normal
hematopoietic system phenotype |
J:136653
|
reticulocytosis |
J:94190
|
Hbbd3th/Hbbd3th Tg(HBB-AR-HBA2,-HBB*)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0
involves: FVB/N * Swiss Webster
|
abnormal brain morphology |
J:94190
|
abnormal erythrocyte morphology |
J:94190
|
abnormal hemoglobin |
J:94190
|
abnormal kidney afferent arteriole morphology |
J:94190
|
abnormal liver morphology |
J:94190
|
abnormal neuron morphology |
J:94190
|
abnormal spleen morphology |
J:94190
|
abnormal urine homeostasis |
J:94190
|
anemia |
J:94190
|
brain vascular congestion |
J:94190
|
decreased urine osmolality |
J:94190
|
enlarged kidney |
J:94190
|
enlarged liver |
J:94190
|
enlarged spleen |
J:94190
|
glomerular capillary congestion |
J:94190
|
increased circulating alanine transaminase level |
J:94190
|
increased circulating aspartate transaminase level |
J:94190
|
increased mean corpuscular hemoglobin |
J:94190
|
increased spleen red pulp amount |
J:94190
|
liver fibrosis |
J:94190
|
postnatal lethality |
J:94190
|
premature death |
J:94190
|
pulmonary alveolar hemorrhage |
J:94190
|
pulmonary interstitial fibrosis |
J:94190
|
pulmonary vascular congestion |
J:94190
|
renal fibrosis |
J:94190
|
reticulocytosis |
J:94190
|
spleen fibrosis |
J:94190
|
spleen vascular congestion |
J:94190
|
thick pulmonary interalveolar septum |
J:94190
|
Hbbd3th/Hbbd3th Tg(LCR-HBA2,LCR-HBB)11Cos/0
involves: FVB/N
|
abnormal erythrocyte morphology |
J:94190
|
increased mean corpuscular hemoglobin |
J:94190
|
reticulocytosis |
J:94190
|
Hbbtm1.1(HBG1,HBB*)Ryan/Hbb+
involves: C57BL/6J
|
abnormal bone marrow cavity morphology |
J:147906
|
abnormal iron level |
J:147906
|
abnormal spleen morphology |
J:147906
|
anisopoikilocytosis |
J:147906
|
decreased erythrocyte cell number |
J:147906
|
decreased mean corpuscular hemoglobin |
J:147906
|
decreased mean corpuscular hemoglobin concentration |
J:147906
|
decreased mean corpuscular volume |
J:147906
|
enlarged spleen |
J:147906
|
extramedullary hematopoiesis |
J:147906
|
increased erythroid progenitor cell number |
J:147906
|
increased hemoglobin concentration distribution width |
J:147906
|
increased liver iron level |
J:147906
|
increased spleen iron level |
J:147906
|
increased spleen red pulp amount |
J:147906
|
intermingled spleen red and white pulp |
J:147906
|
microcytic anemia |
J:147906
|
reticulocytosis |
J:147906
|
Hbbtm1.1(HBG1,HBB*)Ryan/Hbbtm1.1(HBG1,HBB*)Ryan
involves: C57BL/6J
|
perinatal lethality, complete penetrance |
J:147906
|
Hbbtm2Unc/Hbb+
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal erythrocyte morphology |
J:64295
|
anisocytosis |
J:64295
|
decreased erythrocyte cell number |
J:64295
|
decreased hematocrit |
J:64295
|
decreased hemoglobin content |
J:64295
|
decreased mean corpuscular volume |
J:64295
|
enlarged spleen |
J:64295
|
extramedullary hematopoiesis |
J:64295
|
increased hemoglobin concentration distribution width |
J:64295
|
increased kidney iron level |
J:64295
|
increased liver iron level |
J:64295
|
increased mean corpuscular hemoglobin concentration |
J:64295
|
increased spleen iron level |
J:64295
|
poikilocytosis |
J:64295
|
Hbbtm2Unc/Hbbtm2Unc
involves: 129P2/OlaHsd * C57BL/6J
|
decreased birth body size |
J:64295
|
pallor |
J:64295
|
postnatal lethality, complete penetrance |
J:64295
|